Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

BACKGROUND: The combination of gemcitabine and docetaxel (GT) has been demonstrated to be effective against various types of solid tumors, including sarcoma. However, the regimen has not been confirmed in large, well-designed clinical trials in refractory metastatic osteosarcoma. METHODS: We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Guo, Wei, Xie, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192345/
https://www.ncbi.nlm.nih.gov/pubmed/30326879
http://dx.doi.org/10.1186/s12885-018-4872-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192345/
https://www.ncbi.nlm.nih.gov/pubmed/30326879
http://dx.doi.org/10.1186/s12885-018-4872-x

Ejemplares similares